Friday, 27 May 2022
  
Login

Australia's most trusted
source of pharma news

Friday, 27 May 2022
News

Aust price cuts not the worst

Posted 21 January 2022 PM

While the average price of branded pharmaceuticals in Australia is going backwards a global survey has found that in the United States, prices have soared by more than 18 per cent every year since 2017.

According to data analytics company GlobalData, the price of branded drugs in Australia fell by an annual average of 3.54 per cent between 2017-2021, a drop not as sharp as that experienced in some other developed nations.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (9)

Sales & Customer Relations (38)

Access & Reimbursement (4)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (5)

Devices (2)

Other (28)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.